Clinical Trial Update: Expanded Access Study for Renal Transplant Patients With Envarsus XR ™

View source ↗

Summary

Marketing approval has been granted for Envarsus XR in renal transplant patients within the context of an expanded access study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Failure

Drugs mentioned

• Envarsus XR (Tacrolimus)

Snippet

Sponsor: Veloxis Pharmaceuticals | Conditions: Renal Failure | Status: APPROVED_FOR_MARKETING